{"text": ["M&A,", "Innovation", "&", "New", "Drugs", "to", "Drive", "Pharma", "Stocks"], "created_at": "2018-03-08 22:00:10"}
{"text": ["Want", "to", "be", "a", "Buy", "and", "Hold", "Investor?", "3", "Strategies"], "created_at": "2018-03-08 17:52:24"}
{"text": ["Want", "to", "be", "a", "Buy", "and", "Hold", "Investor?", "3", "Strategies"], "created_at": "2018-03-08 17:52:24"}
{"text": ["Want", "to", "be", "a", "Buy", "and", "Hold", "Investor?", "3", "Strategies"], "created_at": "2018-03-08 15:26:03"}
{"text": ["Biotech", "Stock", "Round", "Up:", "Regeneron", "Submits", "sBLA,", "Biogen", "to", "Withdraw", "Zinbryta"], "created_at": "2018-03-08 14:51:25"}
{"text": ["Biotech", "Stock", "Round", "Up:", "Regeneron", "Submits", "sBLA,", "Biogen", "to", "Withdraw", "Zinbryta"], "created_at": "2018-03-08 14:51:25"}
{"text": ["Multimillion-dollar", "drug", "yanked", "from", "market", "connected", "to", "dangerous", "brain", "inflammation", "cases", "in", "U.S."], "created_at": "2018-03-08 13:59:22"}
{"text": ["Multimillion-dollar", "drug", "yanked", "from", "market", "connected", "to", "dangerous", "brain", "inflammation", "cases", "in", "U.S."], "created_at": "2018-03-08 13:59:22"}
{"text": ["Biotech", "Stock", "Round", "Up:", "Regeneron", "Submits", "sBLA,", "Biogen", "to", "Withdraw", "Zinbryta"], "created_at": "2018-03-08 13:19:01"}
{"text": ["Key", "Updates", "on", "BMY\u2019s", "Reyataz", "and", "Hepatitis", "C", "Franchise"], "created_at": "2018-03-08 12:30:52"}
{"text": ["Validea", "John", "Neff", "Strategy", "Daily", "Upgrade", "Report", "-", "3/8/2018"], "created_at": "2018-03-08 09:32:46"}
{"text": ["Validea", "John", "Neff", "Strategy", "Daily", "Upgrade", "Report", "-", "3/8/2018"], "created_at": "2018-03-08 09:32:46"}
